The global microbial identification market accounted for USD 3.69 billion in 2023 and is expected to reach USD 12.66 billion by 2034 with a CAGR of 11.86% during the forecast period 2024-2034. The market will grow as a result of several causes, including the rise in infectious illness cases, the need for point-of-care testing, technical developments, the rapid growth of the pharmaceutical and biotechnology sectors, and the focus on customized therapy.
The technique of microbial identification has been completely transformed by advancements in technologies such as PCR, DNA sequencing, proteomics, and MALDI-TOF mass spectrometry. When compared to conventional approaches, these technologies provide faster, more accurate, and more affordable solutions, which propels market growth. For instance, bioMérieux announced the release of its next-generation microbial identification technology, BacTrac ID-Nanosystems, in January 2024.
By product and services, the consumables segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the increased demand for reagents, kits, and media used in microbial identification assays and testing protocols across various industries such as pharmaceuticals, food and beverage, clinical diagnostics, and environmental testing. For instance, in November 2023, Thermo Fisher Scientific successfully acquired Phitonex, Inc., a company that creates sophisticated reagents for high-resolution flow cytometry. Additionally, the software & services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of advanced software solutions for data analysis, interpretation, and management in microbial identification processes, along with the rising demand for microbial identification services outsourcing, driving market growth.
By technology, the PCR segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the high sensitivity, specificity, and widespread applicability of PCR (Polymerase Chain Reaction) technology in microbial detection and identification across various industries, including clinical diagnostics, pharmaceuticals, and food safety. For instance, Bruker introduced its new MALDI Biotyper Raptor Software Solution for taxonomic categorization and microbiological identification in February 2024. Additionally, the next-generation sequencing segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for high-throughput, cost-effective, and accurate sequencing technologies for microbial identification and characterization, particularly in research, clinical diagnostics, and pharmaceutical applications.
By method, the genotypic segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption of genotypic methods, such as DNA sequencing and microarrays, for precise and rapid microbial identification, driven by advancements in sequencing technologies, bioinformatics, and the need for comprehensive microbial characterization across various industries. For instance, BD announced in January 2024 that it was acquiring Nanostics, Inc., a company that developed liquid biopsy-based prostate cancer diagnosis.
By application, the clinical diagnostics segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the increasing prevalence of infectious diseases and the rising demand for rapid and accurate microbial identification in clinical settings for timely diagnosis and treatment decision-making. For instance, Qiagen announced in October 2023 the release of its QIAseq Multimodal Liquid Biopsy Panel, which allows researchers to concurrently identify and track many cancer biomarkers. Additionally, the pharmaceuticals segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding pharmaceutical industry, increasing emphasis on drug safety and quality control, and growing adoption of microbial identification technologies for product development, manufacturing, and regulatory compliance.
By end-user, the hospitals & diagnostic laboratories segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the rising demand for microbial identification services in hospitals and diagnostic laboratories for accurate diagnosis of infectious diseases, infection control measures, and patient management, coupled with advancements in diagnostic technologies and increasing healthcare expenditure globally. For instance, Merck announced in November 2023 that it would be expanding its BioMonitoring portfolio with the introduction of the EZ-FluoTM Rapid Detection System for the detection of microbiological contamination in beverages. Additionally, the pharmaceutical & biotechnology companies segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding drug development pipelines, increasing emphasis on product quality and safety, and growing adoption of microbial identification technologies for research, development, and manufacturing processes within the pharmaceutical and biotechnology industries.
The North American region is expected to have the highest revenue share during the forecast period due to its robust healthcare infrastructure, technological advancements, high adoption rate of advanced microbial identification technologies, stringent regulatory standards, and rising prevalence of infectious diseases, which are driving demand for microbial identification solutions in North America. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing investments in research and development, rising prevalence of infectious diseases, growing demand for quality food and beverages, and stringent regulatory norms driving the adoption of microbial identification solutions in the Asia Pacific region. For instance, Distributed Bio, Inc., a pioneer in computational antibody creation, was acquired by Charles River Laboratories, as announced in January 2024.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The technique of microbial identification has been completely transformed by advancements in technologies such as PCR, DNA sequencing, proteomics, and MALDI-TOF mass spectrometry. When compared to conventional approaches, these technologies provide faster, more accurate, and more affordable solutions, which propels market growth. For instance, bioMérieux announced the release of its next-generation microbial identification technology, BacTrac ID-Nanosystems, in January 2024.
By product and services, the consumables segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the increased demand for reagents, kits, and media used in microbial identification assays and testing protocols across various industries such as pharmaceuticals, food and beverage, clinical diagnostics, and environmental testing. For instance, in November 2023, Thermo Fisher Scientific successfully acquired Phitonex, Inc., a company that creates sophisticated reagents for high-resolution flow cytometry. Additionally, the software & services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of advanced software solutions for data analysis, interpretation, and management in microbial identification processes, along with the rising demand for microbial identification services outsourcing, driving market growth.
By technology, the PCR segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the high sensitivity, specificity, and widespread applicability of PCR (Polymerase Chain Reaction) technology in microbial detection and identification across various industries, including clinical diagnostics, pharmaceuticals, and food safety. For instance, Bruker introduced its new MALDI Biotyper Raptor Software Solution for taxonomic categorization and microbiological identification in February 2024. Additionally, the next-generation sequencing segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for high-throughput, cost-effective, and accurate sequencing technologies for microbial identification and characterization, particularly in research, clinical diagnostics, and pharmaceutical applications.
By method, the genotypic segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption of genotypic methods, such as DNA sequencing and microarrays, for precise and rapid microbial identification, driven by advancements in sequencing technologies, bioinformatics, and the need for comprehensive microbial characterization across various industries. For instance, BD announced in January 2024 that it was acquiring Nanostics, Inc., a company that developed liquid biopsy-based prostate cancer diagnosis.
By application, the clinical diagnostics segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the increasing prevalence of infectious diseases and the rising demand for rapid and accurate microbial identification in clinical settings for timely diagnosis and treatment decision-making. For instance, Qiagen announced in October 2023 the release of its QIAseq Multimodal Liquid Biopsy Panel, which allows researchers to concurrently identify and track many cancer biomarkers. Additionally, the pharmaceuticals segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding pharmaceutical industry, increasing emphasis on drug safety and quality control, and growing adoption of microbial identification technologies for product development, manufacturing, and regulatory compliance.
By end-user, the hospitals & diagnostic laboratories segment accounted for the highest revenue-grossing segment in the global microbial identification market in 2023 owing to the rising demand for microbial identification services in hospitals and diagnostic laboratories for accurate diagnosis of infectious diseases, infection control measures, and patient management, coupled with advancements in diagnostic technologies and increasing healthcare expenditure globally. For instance, Merck announced in November 2023 that it would be expanding its BioMonitoring portfolio with the introduction of the EZ-FluoTM Rapid Detection System for the detection of microbiological contamination in beverages. Additionally, the pharmaceutical & biotechnology companies segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding drug development pipelines, increasing emphasis on product quality and safety, and growing adoption of microbial identification technologies for research, development, and manufacturing processes within the pharmaceutical and biotechnology industries.
The North American region is expected to have the highest revenue share during the forecast period due to its robust healthcare infrastructure, technological advancements, high adoption rate of advanced microbial identification technologies, stringent regulatory standards, and rising prevalence of infectious diseases, which are driving demand for microbial identification solutions in North America. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing investments in research and development, rising prevalence of infectious diseases, growing demand for quality food and beverages, and stringent regulatory norms driving the adoption of microbial identification solutions in the Asia Pacific region. For instance, Distributed Bio, Inc., a pioneer in computational antibody creation, was acquired by Charles River Laboratories, as announced in January 2024.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product and Service, Technology, Method Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Microbial Identification Market Report 2023 - 2034
Microbial Identification Market Analysis & Forecast by Product and Services 2023 - 2034 (Revenue USD Bn)
- Instruments
- Mass Spectrometers
- PCR Systems
- Microarrays
- Others
- Consumables
- Reagents & Kits
- Plates & Media
- Software & Services
- Identification Services
- Culture Collection Services
- Assay Validation Services
- Mass Spectrometry
- PCR
- Microarrays
- Next Generation Sequencing
- Others
Microbial Identification Market Analysis & Forecast by Method 2023 - 2034 (Revenue USD Bn)
- Phenotypic Methods
- Genotypic Methods
- Proteotypic Methods
Microbial Identification Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Clinical Diagnostics
- Pharmaceuticals
- Food & Beverage Testing
- Environmental Application
- Others
Microbial Identification Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Food Testing Laboratories
- Others
Microbial Identification Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Microbial Identification Market: Product and Services Estimates & Trend Analysis
8. Microbial Identification Market: Technology Estimates & Trend Analysis
9. Microbial Identification Market: Method Estimates & Trend Analysis
10. Microbial Identification Market: Application Estimates & Trend Analysis
11. Microbial Identification Market: End-user Estimates & Trend Analysis
12. Regional Market Analysis
13. North America Microbial Identification Market
14. Europe Global Microbial Identification Market
15. Asia Pacific Global Microbial Identification Market
16. Latin America Global Microbial Identification Market
17. MEA Global Microbial Identification Market
18. Competitor Analysis
19. Company Profiles
Companies Mentioned
- Merck KGaA
- Charles River Laboratories International Inc.
- Shimadzu Corporation
- Eurofins Scientific
- Luminex Corporation
- bioMérieux Inc.
- PerkinElmer Inc.
- Biolog Inc.
- Hologic Inc.
- Hardy Diagnostics.
